Leaders from the international biotechnology and pharmaceutical industries gathered last week for the first annual BioPharm America TM partnering conference. The conference was held on September 9-10 in Atlanta, Georgia. BioPharm America drew 400 delegates representing over 258 companies from 24 countries who engaged in over 900 one–to–one partnering meetings. In addition, there were 11 workshops and panel sessions and 60 presentations by biotech companies seeking financing, licensing opportunities or partners for advancing the development of intellectual property.
By all measures the BioPharm America conference exceeded delegates´ expectations in facilitating their ability to meet with numerous potential partners and discuss in– and out–licensing, financing and other collaborative programs.
Commenting on the conference, Donald Wilson, President and CEO of Endacea, an emerging biotechnology company based in North Carolina´s Research Triangle Park, said, "BioPharm America was an extremely effective conference and an excellent use of my time. I accomplished more here in two days than I have in a long time. Based on my meetings I had here in Atlanta, I can now say that I have spent too much time chasing venture capital financing and not enough time at EBD Group´s partnering conferences."
Dr. Edwin Ades, Associate Director for Laboratory Science, Centers for Disease Control and Prevention, remarked: "BioPharm America was a great experience. This event proved to be an excellent way for me to learn about new science and opportunities for collaboration. I had eight meetings at the conference producing three opportunities that we will follow up on."
Georg Buchner, Vice President, Corporate and Business Development, Novacta Biosystems, a UK–based anti–infective therapeutics company, stated, "Like all EBD Group partnering events, BioPharm America makes meeting people and discovering new opportunities easy. The conference is a good way for European companies to tap into the U.S. market, and the partneringONE TM system efficiently facilitates connections and helps partnerships get started. Having regularly attended EBD Group´s other events, I can confidently say that EBD is a guarantee for partnering productivity."
Phillip Street, Chairman of SouthEase BIO, said, "Southeast BIO (SEBIO) was pleased to support the inaugural BioPharm America conference. We were thrilled to see the high level of participation from companies throughout the Southeast and look forward to the conference returning to the region."
Carola Schropp, President, EBD Group, said, "We extend our thanks to the State of Georgia, GeorgiaBio, and the entire Southeast life science community through the leadership of SouthEast BIO and the North Carolina Biotechnology Center for helping make the first BioPharm America conference a huge success. I also want to thank our numerous supporting sponsors for their generous assistance in hosting this event.
EBD Group is very excited to bring our proven format for partnering to the North American marketplace. Based on the response we received here in Atlanta, next year´s event in San Francisco, September 16-18, should set a new benchmark for productive partnering in the U.S. biotech marketplace."
About BioPharm America TM
BioPharm America TM is where biotech industry partnerships get started. Meet one–to–one with biotech and pharma executives from around the world to identify and enter strategic relationships. BioPharm America is the only partnering event in North America based on the same winning formula as EBD Group´s acclaimed European events BIO–Europe and BIO–Europe Spring®. BioPharm America is simply an unmatched opportunity for companies across the biotech value–chain to meet and do business. For more information please visit www.ebdgroup.com/bpa
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group´s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group´s conferences are run with the support of leading corporations and international trade associations and include:
- BIO–Europe and BIO–Europe Spring®, the world´s largest stand–alone life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America TM, EBD Group´s North American partnering event
- EuroMedtech TM, EBD Group´s new partnering event for the innovative medical technology industry
- BioEquity Europe, the investor conference co–organized with BioCentury Publications and BIO
EBD Group´s sophisticated Web–based partnering service, partneringONE TM, is used as the partnering engine at numerous third–party events around the world. Outside of the conference format, EBD Group´s consultants provide hands–on assistance for firms seeking to in– or out–license products and technologies.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
